Interaction of the H63D mutation in the hemochromatosis gene with the apolipoprotein E epsilon 4 allele modulates age at onset of Alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 15, Issue 3, 2003, Pages 151-154

  Combarros, Onofre ^a   García Román, Marisa ^a   Fontalba, Ana ^a   Fernández Luna, José Luis ^a   Llorca, Javier ^b   Infante, Jon ^a   Berciano, José ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

Alzheimer's disease; Apolipoprotein E; H63D mutation; Hemochromatosis; HFE gene

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENOTYPE; GROUPS BY AGE; HEMOCHROMATOSIS; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; FEMALE; GENOTYPE; HEMOCHROMATOSIS; HUMANS; MALE; MIDDLE AGED; MUTATION; RISK FACTORS; SAMPLING STUDIES;

EID: 12244274984     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068480     Document Type: Article

References (15)

1. Lynch T, Cherny RA, Bush AI: Oxidative processes in Alzheimer's disease: The role of Aβ-metal interactions. Exp Gerontol 2000;35:445-451.
2. Smith MA, Harris PLR, Sayre LM, Perry G: Iron accumulation in Alzheimer d isease is a source of redox-generated free radicals. Proc Natl Acad Sci USA 1997;94:9866-9868.
3. Rao KSJ, Rao RV, Shanmugavelu P, Menon RB: Trace elements in Alzheimer's disease brain: A new hypothesis. Alzheimers Rep 1999;2:241-246.
4. Namekata K, Imagawa M, Terashi A, Ohta S, Oyama F, Ihara Y: Association of transferrin C2 allele with late-onset Alzheimer's disease. Hum Genet 1997;101:126-129.
5. Kim KW, Jhoo JH, Lee JH, Lee DY, Lee KU, Youn JY, Woo JI: Transferrin C2 variant does not confer a risk for Alzheimer's disease in Koreans. Neurosci Lett 2001;308:45-48.
6. Hussain RI, Ballard CG, Edwarson JA, Morris CM: Transferrin gene polymorphism in Alzheimer's disease and dementia with Lewy bodies in humans. Neurosci Lett 2002;317:13-16.
7. Roy CN, Andrews NC: Recent advances in disorders of iron metabolism: Mutations, mechanisms and modifiers. Hum Mol Genet 2001;10:2181-2186.
8. Lyon E, Frank E: Hereditary hemochromatosis since discovery of the HFE gene. Clin Chem 2001;47:1147-1156.
9. Sampietro M, Caputo L, Casatta A, Meregalli M, Pellagatti A, Tagliabue J, Annoni G, Vergani C: The hemochromatosis gene affects the age of onset of sporadic Alzheimer's disease. Neurobiol Aging 2001;22:563-568.
10. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer Disease. Neurology 1984;24:939-944.
11. Sánchez M, Bruguera M, Bosch J, Rodés J, Ballesta F, Oliva R: Prevalence of the Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and in controls. J Hepatol 1998;29:725-728.
12. Moalem S, Percy ME, Andrews DF, Kruck TPA, Wong S, Dalton AJ, Mehta P, Fedor B, Warren AC: Are hereditary hemochromatosis mutations involved in Alzheimer disease? Am J Med Genet 2000;93:58-66.
13. Jolivalt C, Leininger-Muller B, Bertrand P, Herber R, Christen Y, Siest G: Differential oxidation of apolipoprotein E isoforms and interaction with phospholipids. Free Radic Biol Med 2000;28:129-140.
14. Tamaoka A, Miyatake R, Matsuno S, Ishii K, Nagase S, Sahara N, Ono S, Mori H, Wakabayashi K, Tsuji S, Takahashi H, Shoji S: Apolipoprotein E allele-dependent antioxidant activity in brains with Alzheimer's disease. Neurology 2000;54:2319-2321.
15. Lauderback CM, Kanski J, Hackett JM, Maeda N, Kindy MS, Butterfield DA: Apolipoprotein E modulates Alzheimer's Aβ (1-42)-induced oxidative damage to synaptosomes in an allele-specific manner. Brain Res 2002;924:90-97.